Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (The ABC Study)
Phase of Trial: Phase II
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Abatacept (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms ABC
- 06 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 06 Dec 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated